# Protocol Comparison Table  
### Post-Mastectomy Breast Implant Revision  
**Version 2.0 — December 2025**  

[![License: CC BY 4.0](https://img.shields.io/badge/License-CC%20BY%204.0-lightgrey.svg)](https://creativecommons.org/licenses/by/4.0/)

---

## Educational Use Disclaimer

**This comparison table is an educational framework, not an institutional clinical guideline.**

- Developed for pre-medical educational purposes and medical school application portfolio
- NOT approved for clinical use without institutional review and attending physician oversight
- All clinical decisions require attending anesthesiologist judgment and patient-specific assessment
- Does not replace formal anesthesia training, credentialing, or institutional policies
- Author is pre-medical student; content reflects literature synthesis, not clinical expertise

**For clinical implementation:** This framework requires validation by board-certified anesthesiologists, institutional governance review, and integration with local policies.

---

## Abbreviations and Definitions

| Acronym | Definition |
|---------|-----------|
| **OFIA** | Opioid-Free Intraoperative Anesthesia |
| **PECS** | Pectoral Nerve Blocks (PECS I and PECS II) |
| **PONV** | Postoperative Nausea and Vomiting |
| **NRS** | Numeric Rating Scale (0-10 pain scale) |
| **RASS** | Richmond Agitation-Sedation Scale |
| **LAST** | Local Anesthetic Systemic Toxicity |
| **MME** | Morphine Milligram Equivalents (oral) |
| **OSA** | Obstructive Sleep Apnea |
| **PACU** | Post-Anesthesia Care Unit |
| **ASA** | American Society of Anesthesiologists |
| **QI** | Quality Improvement |

---

## Protocol Hierarchy (Essential Understanding)

**Protocol Selection follows strict hierarchy:**

1. **FIRST-LINE:** Protocol 1 (OFIA + PECS blocks) - Use when feasible
2. **SECOND-LINE:** Protocol 2 (OFIA no blocks) - When blocks contraindicated/refused
3. **THIRD-LINE:** Protocol 3 (Opioid-inclusive) - Reserved for specific indications only

**Protocol 3 is typically reserved for defined indications** when Protocols 1-2 are unsuitable.

**Important:** High-risk patients (OSA STOP-BANG ≥5, frail elderly, Apfel 4) requiring Protocol 3 need:
- Attending discussion and enhanced monitoring plan
- Documented rationale for Protocol 3 selection
- Safety protocols (naloxone preparation, capnography, monitored bed criteria)

---

## Side-by-Side Comparison

| Feature | Protocol 1<br>**OFIA + PECS Blocks**<br>**(First-Line)** | Protocol 2<br>**OFIA No Blocks**<br>**(Second-Line)** | Protocol 3<br>**Opioid-Inclusive**<br>**(Third-Line)** |
|---------|----------------------------------------------------------|-------------------------------------------------------|--------------------------------------------------------|
| **Protocol Line** | **First-line (preferred)** | Second-line | Third-line (reserved) |
| **Primary Goal** | Optimal analgesia + minimal PONV | Opioid-sparing with minimal needles | Familiar technique for specific indications |
| **Typical Needle Exposure** | IV + bilateral PECS blocks (2-4 block needles) | **IV only** | **IV only** |
| **Regional Anesthesia** | PECS I + II bilateral | None | None |
| **Intraop Opioids** | **None (zero)** | **None (zero)** | Fentanyl + hydromorphone |
| **Analgesic Quality** | ★★★★★ (excellent) | ★★★★☆ (good with infiltration) | ★★★☆☆ (variable, rebound pain) |
| **PACU Pain (NRS)** | **1-3/10** | **3-6/10** | **2-4/10 initially → 5-8/10 rebound** |
| **Rescue Analgesia Needed** | **<20%** of patients | **20-40%** of patients | Variable (high in opioid-naïve, higher in tolerant) |
| **PONV Incidence** | **3-8%** (lowest) | **10-15%** (moderate) | **15-25%** (highest, despite prophylaxis) |
| **PONV Risk Level** | ★☆☆☆☆ (very low) | ★★☆☆☆ (low-moderate) | ★★★★☆ (high) |
| **Respiratory Events** | <2% | <2% | **5-10%** (desaturation, oversedation) |
| **Naloxone Use** | <0.5% | <0.5% | **1-3%** |
| **Expected PACU Time** | **60-90 min** | **90-120 min** | **120-180 min** |
| **Emergence Quality** | Very smooth, calm, minimal sedation | Smooth, minimal sedation | Slower, more sedation, higher monitoring needs |
| **Hemodynamic Stability** | Generally stable; monitor for dex-related bradycardia/hypotension, ketamine-related HTN/tachycardia | Generally stable; monitor for dex-related bradycardia/hypotension | Generally stable; monitor for opioid-related hypotension/bradycardia |
| **Surgeon Infiltration** | Recommended (enhances coverage) | **ESSENTIAL** (critical success factor) | Helpful (reduces opioid needs) |
| **Best For** | • High PONV risk (Apfel ≥3)<br>• Major revision/capsulectomy<br>• Anxious patients<br>• **ALL patients when feasible** | • Needle phobia<br>• Blocks contraindicated<br>• Anticoagulation<br>• Time constraints | • Chronic opioid use (>50 MME/day)<br>• Multiple OFIA contraindications<br>• Protocol 1-2 previous failure<br>• Patient explicit preference |
| **Main Contraindications** | • Block site infection<br>• Therapeutic anticoagulation<br>• Patient refusal | • Anticipated severe pain without blocks<br>• Surgeon unable to infiltrate | • Very high PONV risk (Apfel 4)<br>• Severe untreated OSA<br>• Opioid use disorder in recovery |
| **Patient Satisfaction** | Highest (excellent analgesia, low PONV) | High (when expectations set) | Lower (more side effects) |

---

## Multimodal Adjunct Summary

| Agent | Protocol 1<br>(OFIA + Blocks) | Protocol 2<br>(OFIA No Blocks) | Protocol 3<br>(Opioid-Inclusive) |
|-------|-------------------------------|--------------------------------|----------------------------------|
| **Regional Block** | PECS I + II bilateral | None | None |
| **Dexmedetomidine** | 0.2-0.5 mcg/kg/hr<br>(elderly: 0.2-0.4) | 0.2-0.5 mcg/kg/hr<br>(elderly: 0.2-0.4) | Optional 0.2-0.4 mcg/kg/hr |
| **Ketamine (induction)** | 0.2-0.3 mg/kg<br>(elderly: 0.1-0.2) | 0.2-0.3 mg/kg<br>(elderly: 0.1-0.2) | Rarely used |
| **Ketamine (intraop)** | Microboluses 10-20 mg PRN<br>OR infusion 0.1-0.2 mg/kg/hr | Microboluses 10-20 mg PRN<br>OR infusion 0.1-0.2 mg/kg/hr | Rarely |
| **Lidocaine infusion** | 1-1.5 mg/kg/hr<br>(hepatic dysfunction: reduce/avoid) | 1-1.5 mg/kg/hr<br>(hepatic dysfunction: reduce/avoid) | Optional if no contraindications |
| **Fentanyl** | **Goal: zero**<br>(rescue per attending) | **Goal: zero**<br>(rescue per attending) | 1-1.5 mcg/kg induction<br>+ infusion 0.5-1 mcg/kg/hr OR boluses<br>(phenotype-adjusted) |
| **Hydromorphone** | **Goal: zero**<br>(rescue per attending) | **Goal: zero**<br>(rescue per attending) | 0.2-0.4 mg IV end-of-case<br>(≥20 min before extubation) |

**Adjunct Notes:**
- **Protocol 1-2:** Opioid-free goal; small rescue doses permitted for block failure, severe stimulus, or attending judgment
- **Protocol 2:** Conservative ketamine/dex approach validated; higher ranges used selectively when appropriate
- **Protocol 3:** Phenotype-specific dosing (see Protocol 3 document for elderly, OSA, chronic opioid adjustments)

---

## Expected Clinical Outcomes (Comparison)

| Outcome Metric | Protocol 1 | Protocol 2 | Protocol 3 |
|----------------|-----------|-----------|-----------|
| **PACU Pain (NRS)** | 1-3/10 | 3-6/10 | 2-4/10 → 5-8/10 rebound |
| **Rescue Analgesia Rate** | <20% | 20-40% | Variable by tolerance |
| **PONV Incidence** | 3-8% | 10-15% | 15-25% |
| **Respiratory Events** | <2% | <2% | 5-10% |
| **Naloxone Use** | <0.5% | <0.5% | 1-3% |
| **PACU Duration** | 60-90 min | 90-120 min | 120-180 min |
| **Patient Satisfaction** | Highest (excellent analgesia, low PONV) | High (when expectations appropriately set) | Lower (more side effects, longer recovery) |
| **Unplanned Admission** | <2% | <3% | <5% |

**Important Note on Outcome Estimates:**

All outcome ranges are **educational estimates** based on literature synthesis and may not reflect your institutional experience. Actual incidence varies by:
- **Definition used** (e.g., PONV = vomiting only vs nausea + rescue antiemetic; respiratory event = desaturation <90% vs <88% vs naloxone use)
- **Population characteristics** (OSA prevalence, chronic opioid use, Apfel distribution)
- **Prophylaxis adherence** (PONV prophylaxis compliance, multimodal analgesia implementation)
- **Monitoring intensity** (continuous capnography detects more respiratory events than pulse oximetry alone)
- **Anesthetic technique** (TIVA vs volatile, N₂O use, total opioid dose)

**Recommendation:** Replace these estimates with your institution's quality improvement (QI) benchmarks when available. These educational ranges provide starting points for protocol comparison, not validated performance targets.

---

## Quick Decision Guide

### Primary Protocol Selection

| Clinical Scenario | Recommended Protocol | Rationale |
|-------------------|---------------------|-----------|
| **Standard patient, no contraindications** | **Protocol 1** | Best outcomes, first-line |
| **Apfel PONV score ≥3** | **Protocol 1** | Lowest PONV risk |
| **Major revision, extensive dissection** | **Protocol 1** | Superior analgesia |
| **Patient terrified of needles** | **Protocol 2** | Needle-minimizing approach |
| **Anticoagulation/coagulopathy** | **Protocol 2** | Blocks contraindicated |
| **Blocks technically not feasible** | **Protocol 2** | Time/anatomy constraints |
| **Chronic opioid use (>50 MME/day)** | **Protocol 3** (consider P1 if tolerates blocks) | Tolerance to opioid-sparing |
| **Multiple OFIA contraindications** | **Protocol 3** | When dex/ketamine/lidocaine all contraindicated |
| **Protocol 1-2 previous failure (same patient)** | **Protocol 3** | Documented inadequate analgesia |
| **Patient explicitly wants "traditional"** | **Protocol 3** | Autonomy (after informed discussion) |

### Special Populations

| Patient Population | Protocol Recommendation | Key Considerations |
|-------------------|------------------------|-------------------|
| **Elderly (>70 years)** | **Protocol 1 preferred** | If P3 needed: reduce all doses 25-50% |
| **OSA (any severity)** | **Protocol 1 or 2 strongly preferred** | If P3 needed: enhanced monitoring, capnography |
| **Opioid use disorder (recovery)** | **Protocol 1 or 2** (avoid opioids) | Minimize relapse risk |
| **Very high PONV risk (Apfel 4)** | **Protocol 1** | Avoid Protocol 3 if possible |
| **Needle phobia** | **Protocol 2** | Patient-centered approach |

---

## Monitoring Requirements Summary

| Monitoring Element | Protocol 1 | Protocol 2 | Protocol 3 |
|-------------------|-----------|-----------|-----------|
| **Standard ASA monitors** | Yes | Yes | Yes |
| **PACU vital signs frequency** | Q15 min → Q30 min | Q15 min → Q30 min | **Q10-15 min** initially |
| **Continuous SpO₂ duration** | ~60 min | ~90 min | **Until fully alert (RASS 0)** |
| **RASS scoring** | Q30 min | Q15-30 min | **Q10-15 min** |
| **Capnography** | Rarely needed | Consider if OSA/COPD | **Strongly consider if OSA/elderly/high opioid** |
| **Naloxone at bedside** | Per routine | Per routine | **MANDATORY, prepared/diluted** |

---

## Safety Framework Summary

| Safety Element | Protocol 1 | Protocol 2 | Protocol 3 |
|----------------|-----------|-----------|-----------|
| **LAST risk** | Yes (PECS blocks) | No | No |
| **20% lipid emulsion** | At bedside for blocks | Not needed | Not needed |
| **Opioid late-stacking risk** | No (opioid-free) | No (opioid-free) | **YES - must avoid** |
| **Naloxone protocol** | Standard availability | Standard availability | **Mandatory preparation** |
| **Enhanced monitoring** | Standard | Standard | **Required (respiratory depression risk)** |
| **Monitored bed escalation** | Rare | Rare | **Lower threshold (5-10% cases)** |

---

## Cost and Resource Considerations (Approximate)

| Resource | Protocol 1 | Protocol 2 | Protocol 3 |
|----------|-----------|-----------|-----------|
| **Block equipment** | Ultrasound, needles, LA | None | None |
| **Medication cost** | Moderate (dex, ketamine, LA) | Moderate (dex, ketamine) | Low (opioids inexpensive) |
| **PACU time** | Shortest (60-90 min) | Moderate (90-120 min) | **Longest (120-180 min)** |
| **Nursing resources** | Standard | Standard | **Enhanced (closer monitoring)** |
| **Unplanned admission** | Lowest (<2%) | Low (<3%) | Higher (<5%) |
| **Overall cost-effectiveness** | **Best** (shorter stay, fewer complications) | Good | Lower (longer stay, more complications) |

---

## Protocol Selection Flowchart
```
START: Post-Mastectomy Breast Implant Revision
    ↓
Are regional blocks FEASIBLE and SAFE?
    ├─ YES → Does patient CONSENT to blocks?
    │         ├─ YES → **PROTOCOL 1** (First-Line)
    │         └─ NO (needle phobia/refusal) → **PROTOCOL 2** (Second-Line)
    │
    └─ NO (contraindicated) → **PROTOCOL 2** (Second-Line)
              ↓
Is Protocol 2 appropriate and expected to provide adequate analgesia
(with surgeon infiltration planned)?
              ├─ YES → **PROTOCOL 2**
              └─ NO → Check specific indications for Protocol 3:
                       ├─ Chronic opioid use (>50 MME/day)?
                       ├─ Multiple OFIA adjunct contraindications?
                       ├─ Prior Protocol 1–2 failure in same patient?
                       ├─ Patient explicit preference after counseling?
                       │
                       ├─ NO to all → **Reconsider Protocol 1 or 2**
                       └─ YES to any → **PROTOCOL 3** (Third-Line)
                                         ↓
                                    **SAFETY GATE (if Protocol 3):**
                                    - OSA very high risk (STOP-BANG ≥5)?
                                    - Frail/elderly (e.g., >75) or high sedation risk?
                                    - Very high PONV risk (Apfel 4)?
                                         ↓
                                    If YES → Enhanced plan required:
                                             • Attending discussion documented
                                             • Capnography strongly considered
                                             • Naloxone prepared/diluted at bedside
                                             • Lower threshold for monitored bed
                                         ↓
                                    **PROTOCOL 3** with Enhanced Safety
```

---

## Bottom Line Summary

| Patient Preference / Clinical Situation | Choose | Avoid |
|----------------------------------------|--------|-------|
| **Best overall outcomes** | **Protocol 1** | - |
| **High PONV risk** | **Protocol 1** | Protocol 3 |
| **Needle phobia** | **Protocol 2** | Protocol 1 |
| **Blocks contraindicated** | **Protocol 2** | Protocol 1 |
| **Chronic opioid use** | **Protocol 3** (or Protocol 1 if blocks feasible) | Inadequate dosing |
| **OSA** | **Protocol 1 or 2** | Protocol 3 if possible |
| **Elderly and frail** | **Protocol 1 or 2** | Protocol 3 if possible |
| **Opioid use disorder (recovery)** | **Protocol 1 or 2** | Protocol 3 |
| **Very high PONV risk (Apfel 4)** | **Protocol 1** | Protocol 3 |
| **Major revision/capsulectomy** | **Protocol 1** | Protocol 2 alone |

---

## Key Takeaways

### For Optimal Patient Outcomes:

1. **Default to Protocol 1 when feasible** - best analgesia, lowest PONV, highest satisfaction
2. **Protocol 2 when blocks not possible** - still opioid-sparing, acceptable outcomes with good surgeon infiltration
3. **Protocol 3 only for specific indications** - reserve for chronic opioid users or when Protocols 1-2 truly inappropriate
4. **Patient-centered selection** - consider patient preferences, comorbidities, and surgical factors
5. **Safety first** - all protocols include comprehensive safety frameworks; Protocol 3 requires enhanced monitoring

### Common Misconceptions to Avoid:

**"Protocol 3 is easier/faster"**  
✓ Actually requires MORE monitoring and LONGER PACU time

**"All patients need opioids for surgery"**  
✓ Protocols 1-2 demonstrate opioid-free approaches are safe and effective when appropriately applied

**"Protocol 2 is just as good as Protocol 1"**  
✓ Protocol 1 outcomes are generally superior when blocks are feasible; Protocol 2 is appropriate alternative

**"Chronic opioid patients can't have opioid-free anesthesia"**  
✓ Protocol 1 with blocks can work for some tolerant patients; Protocol 3 often needed for high tolerance

**"Hemodynamics are always 'excellent' with OFIA"**  
✓ Dexmedetomidine can cause bradycardia/hypotension; ketamine can cause HTN/tachycardia; monitor accordingly

---

## Version History

**Version 2.1 — December 2025**
- Updated educational estimates (literature-informed; institution-dependent)
- Outcome ranges require validation with local QI data
- Protocol 2 adjunct dosing aligned with conservative framework
- Hemodynamic stability descriptions physiologically accurate
- Acronyms defined, governance-safe language throughout

**Version 2.0 — December 2025**
- Protocol hierarchy emphasized (first/second/third-line)
- Expected outcomes quantified for all three protocols
- Safety framework comparison added
- Special populations guidance integrated

**Version 1.0 — December 2025**
- Initial comparison table

---

## Author and License

**Author:** Collin B. George, BS  
**Project Type:** Educational pre-medical protocol framework  
**Status:** Not validated for clinical use; requires institutional review

**License:** Creative Commons Attribution 4.0 International (CC BY 4.0)

**Acknowledgment:**  
This comparison synthesizes the three individual protocol documents, providing quick reference for protocol selection. All clinical decisions require attending anesthesiologist judgment and patient-specific assessment.

---

**End of Protocol Comparison Table** — *Educational resource only.*
